𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma

✍ Scribed by Waters, J S; Moss, C; Pyle, L; James, M; Hackett, S; A'Hern, R; Gore, M; Eisen, T

Book ID
109998304
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
115 KB
Volume
91
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Phase I trial of fixed dose rate gemci
A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma
✍ Brian I. Rini; Vivian Weinberg; Eric J. Small πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Metastatic renal cell carcinoma (RCC) has modest response rates to chemotherapy with gemcitabine and 5‐fluorouracil (5‐FU). Fixed dose rate gemcitabine infusion leads to enhanced intracellular accumulation of drug and possible augmented clinical effect. To determine the t

Phase II trial of carboplatin, gemcitabi
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site
✍ Bryan J. Schneider; Basil El-Rayes; Jeffery H. Muler; Philip A. Philip; Gregory πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP). ## METHODS. Patients with CUP received carboplatin AUC 5 mg/mL a minute intraven